Expertise in
7
conditions

Dr. Lauren E. Henke

Radiation Oncology
University Hospitals
11100 Euclid Ave, 
Cleveland, OH 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
7
conditions
University Hospitals
11100 Euclid Ave, 
Cleveland, OH 

Overview

Lauren Henke is a Radiation Oncologist practicing medicine in Cleveland, Ohio.

Dr. Henke is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Anal Cancer, Familial Pancreatic Cancer, and Thyroidectomy.

She is actively involved in clinical research, co-authoring 98 peer reviewed articles and participating in 17 clinical trials. Dr. Henke is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in MO

Hospital Affiliations

Uh Cleveland Medical Center
Uh Regional Hospitals
Parma Community General Hospital
Uh St John Medical Center
Southwest General Health Center

Languages Spoken

English
Spanish

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
SummaCare
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

University Hospitals
11100 Euclid Ave, Cleveland, OH 44106

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

17 Clinical Trials

Phase I/II Study of Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
Phase I/II Study of Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
Enrollment Status: Recruiting
Publish Date: February 11, 2026
Intervention Type: Radiation, Drug
Study Phase: Phase 1/Phase 2
Phase I Study of Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer
Phase I Study of Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 13, 2026
Intervention Type: Other, Drug, Radiation, Procedure
Study Drugs: Carboplatin, Paclitaxel
Study Phase: Phase 1
A Randomized Phase II Study of De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)
A Randomized Phase II Study of De-Intensified ChemoRadiation for Early-Stage Anal Squamous Cell Carcinoma (DECREASE)
Enrollment Status: Active_not_recruiting
Publish Date: July 10, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Capecitabine, Fluorouracil, Mitomycin
Study Phase: Phase 2
Phase II Study of Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma
Phase II Study of Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma
Enrollment Status: Active_not_recruiting
Publish Date: May 08, 2026
Intervention Type: Procedure, Device, Drug
Study Drug: Defactinib
Study Phase: Phase 2
Non-Operative Management and Early Response Assessment in Rectal Cancer
Non-Operative Management and Early Response Assessment in Rectal Cancer
Enrollment Status: Completed
Publish Date: May 01, 2026
Intervention Type: Drug, Radiation
Study Phase: Not Applicable
A Single-Arm Phase II Study With a Safety Lead-in of Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer
A Single-Arm Phase II Study With a Safety Lead-in of Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: November 12, 2025
Intervention Type: Drug, Device, Biological, Radiation
Study Drugs: Paclitaxel, Carboplatin AUC, Durvalumab
Study Phase: Phase 2
Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy (IMPT) in the Reirradiation of Locoregionally Recurrent Rectal Cancer - IMPARC
Hypofractionated Pencil-Beam Scanning Intensity-modulated Proton Therapy (IMPT) in the Reirradiation of Locoregionally Recurrent Rectal Cancer - IMPARC
Enrollment Status: Terminated
Publish Date: September 29, 2025
Intervention Type: Radiation, Device
Study Phase: Not Applicable
Pilot Study of Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy (MAP-RT)
Pilot Study of Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy (MAP-RT)
Enrollment Status: Completed
Publish Date: January 10, 2025
Intervention Type: Device, Radiation
Study Phase: Not Applicable
Pre-operative Adaptive Short Course Radiation Therapy in Gastric Cancer
Pre-operative Adaptive Short Course Radiation Therapy in Gastric Cancer
Enrollment Status: Terminated
Publish Date: January 09, 2025
Intervention Type: Radiation, Drug
Study Phase: Phase 2
A Prospective Imaging Study of Target Definition and Simulation-free Planning Workflows on the Halcyon 4.0 System for Patients Receiving Radiation Therapy
A Prospective Imaging Study of Target Definition and Simulation-free Planning Workflows on the Halcyon 4.0 System for Patients Receiving Radiation Therapy
Enrollment Status: Completed
Publish Date: October 21, 2024
Intervention Type: Device
Study Phase: Not Applicable
View 9 Less Clinical Trials

98 Total Publications

Data and Dogma in Hepatocellular Carcinoma.
Data and Dogma in Hepatocellular Carcinoma.
Journal: International journal of radiation oncology, biology, physics
Published: January 06, 2026
Similar Doctors
Expertise in
51
conditions
Dr. Samuel Chao
Radiation Oncology
Expertise in
51
conditions
Dr. Samuel Chao
Radiation Oncology
Referral may be required
Before you request

Cleveland Clinic Main Campus

10201 Carnegie Avenue, 
Cleveland, OH 
 (0.6 miles away)
866-223-8100
Experience:
29+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Samuel Chao is a Radiation Oncologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 29 years. Dr. Chao is highly rated in 51 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Glioma, Astrocytoma, Glioblastoma, and Gamma Knife Radiosurgery. Dr. Chao is board certified in American Board Of Radiology, 2007. Dr. Chao is currently accepting new patients.

Expertise in
52
conditions
Dr. John H. Suh
Radiation Oncology
Expertise in
52
conditions
Dr. John H. Suh
Radiation Oncology
Referral may be required

Cleveland Clinic Main Campus

9500 Euclid Avenue, 
Cleveland, OH 
 (0.9 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Suh is a Radiation Oncologist practicing medicine in Cleveland, Ohio. Dr. Suh is highly rated in 52 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Glioma, Astrocytoma, Glioblastoma, and Gamma Knife Radiosurgery. Dr. Suh is currently accepting new patients.

Expertise in
31
conditions
Dr. Michael A. Weller
Radiation Oncology
Expertise in
31
conditions
Dr. Michael A. Weller
Radiation Oncology
Referral may be required

Hillcrest Hospital

6780 Mayfield Rd, 
Mayfield Heights, OH 
 (8.9 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Michael Weller is a Radiation Oncologist practicing medicine in Mayfield Heights, Ohio. Dr. Weller is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, Thrombectomy, and Gamma Knife Radiosurgery.

Frequently Asked Questions about Dr. Lauren E. Henke

How do I make an appointment with Dr. Lauren E. Henke?

You can book an appointment with Dr. Lauren E. Henke by calling their office at 216-286-3900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Lauren E. Henke a top-rated expert for Pancreatic Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Lauren E. Henke is classified as an Distinguished expert for Pancreatic Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Lauren E. Henke specialize in?

While Dr. Lauren E. Henke is a Radiation Oncology, they have specific expertise in Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), and Anal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Lauren E. Henke participate in research or clinical trials?

Yes. Dr. Lauren E. Henke has published 98 articles and abstracts on conditions like Pancreatic Cancer. You can view a list of Dr. Lauren E. Henke's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Lauren E. Henke accept my insurance?

Dr. Lauren E. Henke accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 216-286-3900 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Henke's expertise for a condition
ConditionClose
    View All 42 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile